PTK2 and Hypercholesterolemia: In the present study, we showed early onset of podocyte foot process effacement and proteinuria in a rat model of hypercholesterolaemia, with aberrant phosphorylation of FAK and p38, which were restored and prohibited by oral administration of TAE226, a reported inhibitor of FAK.